Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Hayman

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Leukemia|October 29, 2011
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategiesS Sinha, M A Gertz, M Q Lacy, et al.
Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.
Leukemia|August 30, 2017
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Bone Marrow Transplantation|July 5, 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or olderE Muchtar, D Dingli, S Kumar, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Blood Cancer Journal|March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantationV Roy, A K Stewart, P L Bergsagel, et al.
Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.
Leukemia|October 26, 2013
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patientsS K Kumar, A Dispenzieri, M Q Lacy, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Leukemia|October 29, 2011
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategiesS Sinha, M A Gertz, M Q Lacy, et al.
Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.
Leukemia|August 30, 2017
Outcomes of maintenance therapy with lenalidomide or bortezomib in multiple myeloma in the setting of early autologous stem cell transplantationR Chakraborty, E Muchtar, S K Kumar, et al.
Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Bone Marrow Transplantation|July 5, 2016
Autologous stem cell transplant for multiple myeloma patients 70 years or olderE Muchtar, D Dingli, S Kumar, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Blood Cancer Journal|March 21, 2015
Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem cell transplantationV Roy, A K Stewart, P L Bergsagel, et al.
Bone Marrow Transplantation|April 11, 2006
Allogeneic stem cell transplantation and donor lymphocyte infusions for chronic myelomonocytic leukemiaM A Elliott, A Tefferi, W J Hogan, et al.
Leukemia|October 26, 2013
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patientsS K Kumar, A Dispenzieri, M Q Lacy, et al.
Pageof 6